# A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

> **NCT00001302** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 80 (—)

## Conditions studied

- Breast Cancer
- Kidney Neoplasm
- Lymphoma
- Neoplasm Metastasis
- Ovarian Cancer

## Interventions

- **DRUG:** PSC 833

## Key facts

- **NCT ID:** NCT00001302
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-09
- **Primary completion:** —
- **Final completion:** 2002-06
- **Target enrollment:** 80 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001302, "A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00001302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*